Travel grant applications for the Face-to-Face meeting are being accepted until 24 April 2019.
What is Bioschemas?
Bioschemas aims to improve data interoperability in life sciences. It does this by encouraging people in life science to use schema.org markup, so that their websites and services contain consistently structured information. This structured information then makes it easier to discover, collate and analyse distributed data.
The main outcome of Bioschemas is a collection of specifications that provide guidelines to facilitate a more consistent adoption of schema.org markup within the life sciences.
Bioschemas started as a community effort in November 2015. It operates as an open community initiative with more than 200 people from a wide variety of institutions. You are welcome to join the community.
Schema.org provides a way for us to add semantic markup to web pages. It describes ‘types’ of information, which then have ‘properties’. For example, ‘Event’ is a type that has properties like ‘startDate’, ‘endDate’ and ‘description’. If types or properties needed in the life sciences are missing, then Bioschemas proposes their adoption by Schema.org.
Schema.org is a community effort supported by the main search engines, and is already widely implemented across the web.
Bioschemas for generic types
Schema.org defines common generic types like events and datasets which can be used not just in life sciences but in many other disciplines. Bioschemas is working on specifications to improve the description of generic types in life sciences. The dataset markup properties that Bioschemas specifies as mandatory will also make them findable by Google's Dataset Search.
Bioschemas for biological types
At the moment biological content types like pathways and proteins are not well represented in schema.org. Bioschemas aims to engage with life science communities relying on existing community agreements to bring forward new biological types to schema.org.
The Bioschemas Community have received funding through the ELIXIR-EXCELERATE grant and ELIXIR Implementation Studies. Full details of funding can be on our funding page.
19 June 2019